![Jean de Gunzburg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Origen de la red de primer grado Jean de Gunzburg.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Cardiawave SA
![]() Cardiawave SA Medical SpecialtiesHealth Technology Cardiawave SA develops non-invasive medical device to treat a heart condition called aortic stenosis. The company was founded by Emmanuel Messas, Benjamin Bertrand, Mickaël Tanter, Mathieu Pernot and Mathias Fink on October 21, 2014 and is headquartered in Paris, France.
3
| Holding Company | Medical Specialties | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jean de Gunzburg a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Institut Gustave Roussy EURL
![]() Institut Gustave Roussy EURL Miscellaneous Commercial ServicesCommercial Services Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Universite Paris Cite | College/University | Graduate Degree | |
INSERM Transfert Initiative SAS
![]() INSERM Transfert Initiative SAS Investment ManagersFinance INSERM Transfert Initiative SAS is a venture capital fund that invests in companies located in France. It targets startups from the life sciences and biotechnology sectors, developing new medical practices with a strong intellectual property. It invests between €1 million and €3 million per company during mostly at pre-seed, seed and early-stages. | Investment Managers | Chairman | |
AELIS FARMA | Biotechnology | Director/Board Member | |
BERGENBIO ASA | Pharmaceuticals: Major | Director/Board Member | |
Axilum Robotics SAS
![]() Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Axilum Robotics SAS develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures. Its first project is a robot to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation (TMS). The firm's project TMS is a painless, non invasive medical technique that applies high intensity magnetic impulses to cortex areas by placing a coil on the surface of the head. The company was founded by Bernard Bayle, Michel Berg, Michel de Mathelin, Romuald Ginhoux, Benjamin Maurin and Pierre Renaud in April 2011 and is headquartered in Strasbourg, France. | Miscellaneous Commercial Services | Director/Board Member | |
Sofimac Régions SAS
![]() Sofimac Régions SAS Investment ManagersFinance Sofimac Régions SAS is a Private Equity/Venture Capital firm, a subsidiary of Sofimac Investment Managers SAS founded in 1978. Sofimac Régions is headquartered in Clermont-Ferrand. | Investment Managers | Private Equity Investor | |
Thomas Conseil | Corporate Officer/Principal | ||
Biomodex SAS
![]() Biomodex SAS Commercial Printing/FormsCommercial Services Biomodex SAS develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. It offers simulators for surgical procedures such as bone drilling, soft tissue suturing, medical device implantation, and sizing. The company was founded by Thomas Marchand and Sidarth Radjou on January 22, 2015 and is headquartered in Paris, France. | Commercial Printing/Forms | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Masters Business Admin | |
Eyevensys SAS
![]() Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Step Pharma SAS
![]() Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
SENSORION | Pharmaceuticals: Major | Director/Board Member | |
Inotrem SA
![]() Inotrem SA BiotechnologyHealth Technology Inotrem SA specializes in the development of therapeutic approaches based on its proprietary TREM-1 platform. The firm focuses on the control of immune reactions in acute inflammatory diseases. The company was founded by Jean-Jacques Garaud, Marc Derive and Sebastien Gibot in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
GamaMabs Pharma SA
![]() GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member | |
Bioserve Ltd. | Chief Executive Officer | ||
CropDesign NV
![]() CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member | |
IPSEN | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Quadrille Capital SAS
![]() Quadrille Capital SAS Investment ManagersFinance Quadrille Capital SAS (Quadrille Capital) is an independent private equity firm founded in 2007. The firm is headquartered in Paris, France with an additional office in United States. | Investment Managers | Private Equity Investor |
Estadísticas
Internacional
Francia | 19 |
Noruega | 2 |
Estados Unidos | 2 |
Reino Unido | 2 |
Bélgica | 2 |
Sectorial
Health Technology | 10 |
Finance | 7 |
Commercial Services | 6 |
Consumer Services | 2 |
Health Services | 2 |
Operativa
Director/Board Member | 15 |
Chairman | 3 |
Private Equity Investor | 3 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Las relaciones más conectadas
Insiders | |
---|---|
François Thomas | 25 |
Emmanuel Blanc | 1 |
Armelle Graciet | 1 |
- Bolsa de valores
- Insiders
- Jean de Gunzburg
- Conexiones Empresas